CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

November 9, 2026 · earnings

IMVT earnings: a positive outcome, +15.1%

On November 9, 2026, Immunovant, Inc. reached its earnings. The result was a positive outcome, and the stock moved +15.1% in the window around the event.

The move

$30.53
1d before
$35.15
Event day
$35.71
1d after
$35.05
5d after

Our prediction vs. the result

CatalystAlert called this one neutral (+0.6% expected); the stock actually moved +15.1%. Model confidence at the time: 40%.

See the full scored track record

Pre-catalyst setup

+0.2%
30-day run-up
4835%
30-day volatility
1.9×
volume spike